IP Library Granted Patent US 6,846,641
Granted Patent B2
US 6,846,641 · App. 10/131,731 · Granted Jan 25, 2005

In vitro ischemia model

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,846,641
App. No.
10/131,731
Granted
Jan 25, 2005
Kind
B2
Abstract

A tissue culture model of oxygen/glucose deprivation induced cell death is provided, which is useful in the analysis of the mechanisms of cell death following brain ischemia, and for screening anti-ischemic drugs. By adopting the in vivo concentrations of calcium, potassium and hydrogen ions to the incubation medium a model is established that shows conspicuous similarities with the temporal and special development of cell death in vivo: selective and delayed CA1 damage, a damage mitigated by blockade of the NMDA and AMPA receptors, and a striking augmentation of damage by high levels of glucose.

Claims (21)

1. An ischemic cell culture, comprising:

a culture comprising hippocampal tissue, and a medium for simulation of ischemia, comprising potassium at a concentration of from about 50 mM to 90 mM; calcium at a concentration of from about 0.1 mM to 1 mM; NaCl at a concentration of from about 30-77 mM; at a pH of from 6.7 to 6.9,

wherein when said cells are exposed to said medium for a period of time sufficient to mimic the effects of ischemia in vivo the ischemic effects include a selective and delayed, glutamate receptor dependent cell death in the CA1 region.

2. The method according to claim 1 , wherein said cells comprise a section of brain tissue.

3. An ischemic cell culture, comprising:

a culture comprising hippocampal tissue, and a glucose free medium for simulation of ischemia, comprising potassium at a concentration of from about 50 mM to 90 mM; calcium at a concentration of from about 0.1 mM to 1 mM; at a pH of from 6.7 to 6.9,

wherein when said cells are exposed to said medium for a period of time sufficient to mimic the effects of ischemia in vivo the ischemic effects include a selective and delayed, glutamate receptor dependent cell death in the CA1 region.

4. The culture according to claim 1 , wherein glucose is present in said medium.

5. A method of simulating ischemia in vitro, the method comprising:

exposing a culture comprising hippocampal tissue to a medium for simulation of ischemia, said medium comprising potassium at a concentration of from about 50 mM to 90 mM; calcium at a concentration of from about 0.1 mM to 1 mM; at a pH from 6.7 to 6.9,

wherein when said cells are exposed to said medium for a period of time sufficient to mimic the effects of ischemia in vivo the ischemic effects include a selective and delayed, glutamate receptor dependent cell death in the CA1 region.

6. The method according to claim 1 , wherein said cells comprise a section of brain tissue.

7. The method according to claim 1 , wherein said medium is glucose free.

8. The method according to claim 1 , wherein glucose is present in said medium.

9. A method for determining the effect of a candidate agent on ischemia, the method comprising:

exposing a culture comprising hippocampal tissue to said candidate agent before, during, or after said cells are exposed to a medium for simulation of ischemia, said medium comprising potassium at a concentration of from about 50 mM to 90 mM; calcium at a concentration of from about 0.1 mM to 1 mM; at a pH of from 6.7 to 6.9 ,

wherein when said cells are exposed to said medium for a period of time sufficient to mimic the effects of ischemia in vivo the ischemic effects include a selective and delayed, glutamate receptor dependent cell death in the CA1 region;

comparing at least one parameter of said cells in the presence of said candidate agent and in a control wherein said agent is absent.

10. The method according to claim 9 , wherein said cells comprise a section of brain tissue.

11. The method according to claim 9 , wherein said medium is glucose free.

12. The method according to claim 9 , wherein glucose is present in said medium.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 4, 2020
From: OXISCIENCE, LLC
To: CLINTON MEADE, LENDER RESPRESENTATIVE
Reel/Frame 053452/0507 →
RELEASE OF SECURITY INTEREST Recorded Mar 27, 2006
From: GENERAL ELECTRIC CAPITAL CORPORATION
To: AGY THERAPEUTICS, INC.
Reel/Frame 017366/0336 →
SECURITY AGREEMENT Recorded Jan 13, 2006
From: AGY THERAPEUTICS, INC.
To: GENERAL ELECTRIC CAPITAL CORPORATION
Reel/Frame 017015/0108 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 26, 2003
From: WIELOCH, TADEUSZ; RYTTER, ANNA; CRONBERG, TOBIAS
To: AGY THERAPEUTICS, INC.
Reel/Frame 013878/0215 →